>>> After Hours Summary: MRNA -1.5% trades slightly lower but got FDA panel thum

After Hours Summary: MRNA -1.5% trades slightly lower but got FDA panel thumbs up; FDX -3.3%, BB -2.8% trade lower despite earnings beats

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: None

Companies trading higher in after hours in reaction to news: MREO +35.7% (MREO and RARE announce collaboration and license agreement for setrusumab), DMTK +25% (announces positive results of TRUST Study), BW +8.8% (thermal segment books new projects), MNKD +5% (announces co-promotion agreement for Thyquidity), TWO +1.9% (increases dividend), PRSP +1.6% (awarded $800 mln Navy contract), AR +1.4% (S&P outlook revised to stable from negative), MODN +0.8% (to acquire Deloitte's life sciences pricing and contracting solutions business), CSCO +0.3% (COO steps down), WMB +0.2% (announces bankruptcy court approval for resolution reached with Chesapeake), FLGT +0.2% (PRAH enhances COVID-19 monitoring program via collaboration with FLGT and PWNHealth), HON +0.2% (awarded $1.1 bln Army contract), JBGS +0.1% (new CFO), ALEX +0.1% (reinstates dividend), SWI +0.1% (provides update on cyber attack), ABT +0.1% (FDA expands labeling for HeartMate 3 Heart Pump for use in pediatric patients), RTX +0.1% (awarded $610 mln Air Force contract)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: SCHL -12.7%, SCS -7.7%, X -6% (guides Q4 EPS and EBITDA below consensus), AIR -4.7%, FDX -3.3%, BB -2.8%

Companies trading lower in after hours in reaction to news: MESO -29.3% (provides update on COVID-19 ARDS trial), EGLE -5.8% (stock offering), ASUR -5.3% (stock offering), UPS -2% (in sympathy with FDX earnings report), MRNA -1.5% (confirms receipt of FDA Advisory Committee vote supporting EUA for mRNA-1273), VIR -1.2% (VIR and GSK start of trial evaluating VIR-7831 in hospitalized adults with COVID-19), GLUU -0.3% (files patent infringement lawsuit), AA -0.2% (will halt curtailment plans for smelter in Spain), AMGN -0.1% (receives FDA approval for RIABNI), SNV -0.1% (new CEO), TGI -0.1% (files for mixed securities shelf offering)